Skip to main content
. Author manuscript; available in PMC: 2011 Aug 1.
Published in final edited form as: Neurotoxicology. 2010 May 11;31(4):356–366. doi: 10.1016/j.neuro.2010.04.008

Table 4.

All transcripts regulated b y dieldrin that are involved in the ubiquitin-proteasome pathway (p<0.01). There were significantly more genes induced (19) than down-regulated (3) after treatment to dieldrin.

NR_Accession Gene Name p-value Fold
change
AAW31810 myc binding protein 2 0.0094 −1.42
CAD38880 hect carboxyl terminus domain and RCC1-like domain 2 0.0027 −1.39
AAH45309 ubiquitin-conjugating enzyme E2G 1 0.0034 −1.32
XP_699224 ring finger protein 127 0.0072 1.16
CAG12771 ubiquitin specific peptidase 16 0.0005 1.18
CAF99126 neuralized homolog 0.0055 1.22
AAL75965 f-box and leucine-rich repeat protein 14 0.0006 1.38
CAG02474 anaphase promoting complex subunit 7 0.0013 1.40
AAH44553 ubiquitin specific peptidase 14 0.0019 1.43
CAF95617 u3 small nucleolar RNA-associated protein 18 homolog 0.0046 1.43
AAH44088 ccr4-not transcription complex, subunit 4 0.0038 1.46
AAS45170 bloodthirsty 0.0033 1.46
XP_694020 thyroid hormone receptor interactor 12 0.0004 1.47
CAF94074 baculoviral iap repeat-containing protein 6 <0.0001 1.49
CAA09084 traf-interacting protein 0.0007 1.53
CAG03056 nuclear protein localization 4 <0.0001 1.55
CAG12225 ubiquitin-binding protein homolog 0.0004 1.60
AAH45970 proteasome subunit, alpha type, 4 0.0002 1.60
XP_584914 f-box protein 11 0.0057 1.65
CAH89580 checkpoint with forkhead and ring finger domains 0.0017 1.79
CAG02915 ring finger protein 121 0.0083 1.85
XP_691280 tripartite motif-containing 35 isoform 1 0.0020 1.99